Clinical trial

Phase IV Study of Chronic Infusional Epoprostenol for Severe Primary Pulmonary Hypertension

NCT00004754

Study summary

ClinicalTrials.gov

Phase IV Study of Chronic Infusional Epoprostenol for Severe Primary Pulmonary Hypertension

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record epoprostenol Normalized identity: epoprostenol View linked drug · Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date1993-08-01

PhasePHASE4

Conditions

Hypertension, Pulmonaryunresolved

Interventions

epoprostenolDRUG · verified · RxNorm: epoprostenol

Sponsors & collaborators

National Center for Research Resources (NCRR)lead sponsor

Baylor College of Medicinecollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00004754 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.